Valeant's Battle for Allergan
通常価格
¥1,276 JPY
通常価格
セール価格
¥1,276 JPY
単価
あたり
On April 21, 2014 two companies, Valeant Pharmaceuticals and Pershing Square, announced an unsolicited merger offer for Allergan Pharmaceuticals. The unsolicited offer quickly turned into a hostile acquisition. The following months saw a raging public debate over the future control of Allergan and its primary product, Botox, as well as the business strategies and philosophies of the two offering firms and their CEOs.
【書誌情報】
ページ数:18ページ
サイズ:A4
商品番号:HBSP-TB0523
発行日:2018/8/1
登録日:2018/10/3